Modified insulin-like growth factors

Details Modified insulin-like growth factors Modified insulin-like growth factors

C - Chemistry, Metallurgy

07

K

C07K 17/08 (2006.01) A61K 38/30 (2006.01) A61K 47/48 (2006.01) C07K 14/65 (2006.01)

Patent

CA 2149048

2149048 9412219 PCTABS00032 Modified forms of insulin-like growth factor (IGF) are provided which demonstrate improved pharmacological and biological properties. These modifications include IGF muteins produced by substituting or adding a cysteine in the amino acid sequence of native IGF as well as such muteins attached to polyethylene glycol (PEG) at the free cysteine site. The present invention further provides methods of making such modified forms. The IGF-PEG conjugates can be formulated into pharmaceutical compositions and used for the therapeutic treatment of IGF associated conditions.

Affiliated with

Also associated with

Rating

Modified insulin-like growth factors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified insulin-like growth factors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified insulin-like growth factors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1925436